Research output per year
Research output per year
Unit profile
Description
MultiPark (Multidisciplinary research focused on Parkinson´s disease) is a translational programme that ranges from experimental pre-clinical research to studies on the life situation of patients with neurodegenerative disorders. Our programme not only aims at improving the overall function of patients, but also their acitivity and participation. This initiative relies on solid interactions between Lund University and Skåne University Hospital with support from the University of Gothenburg.
Building on the long tradition of cutting-edge research on neurodegenerative diseases of aging at LU, our vision is to create an innovative environment for improved and novel treatments, disease modifications and eventually cures for neurodegenerative diseases, in order to improve the quality of life for people living and ageing with these disorders.
Research
Further information, please visit Multipark/Research.
UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. Our work contributes towards the following SDG(s):
Collaborations the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
Anita Adami
- Molecular Neurogenetics - Doctoral student
- StemTherapy: National Initiative on Stem Cells for Regenerative Therapy - Doctoral student
- MultiPark: Multidisciplinary research focused on Parkinson´s disease - Doctoral student
Person
-
Henrik Ahlenius
- Stem Cells, Aging and Neurodegeneration - Senior lecturer, Research team manager
- StemTherapy: National Initiative on Stem Cells for Regenerative Therapy - Principal investigator
- LUCC: Lund University Cancer Centre - Principal investigator
- MultiPark: Multidisciplinary research focused on Parkinson´s disease - Principal investigator
Person
-
Muhammad Usman Akbar
- Clinical Memory Research - Postdoctoral fellow
- MultiPark: Multidisciplinary research focused on Parkinson´s disease - Postdoctoral fellow
Person
-
Benchmarking Alzheimer’s disease prediction: personalised risk assessment using polygenic risk scores across various methodologies and genome-wide studies
Mattsson-Carlgren, N., Hansson, O. & Alzheimer's Disease Neuroimaging Initiative, 2025 Dec, In: Alzheimer's Research and Therapy. 17, 1, 6.Research output: Contribution to journal › Article › peer-review
Open Access -
evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer’s disease
Cummings, J. L., Atri, A., Feldman, H. H., Hansson, O., Sano, M., Knop, F. K., Johannsen, P., León, T. & Scheltens, P., 2025 Dec, In: Alzheimer's Research and Therapy. 17, 1, 14.Research output: Contribution to journal › Article › peer-review
Open Access -
Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment
Bolsewig, K., Willemse, E. A. J., Sánchez-Juan, P., Rábano, A., Martínez, M., Doecke, J. D., Bellomo, G., Vermunt, L., Alcolea, D., Halbgebauer, S., in ‘t Veld, S., Mattsson-Carlgren, N., Veverova, K., Fowler, C. J., Boonkamp, L., Koel-Simmelink, M., Hussainali, Z., Ruiters, D. N., Gaetani, L. & Toja, A. & 12 others, , 2025 Dec, In: Nature Communications. 16, 1, 1139.Research output: Contribution to journal › Article › peer-review
Open Access
-
SONOCRAFT: High-throughtput ultrasound-based volumetric 3D printing for tissue engineering
Baasch, T. (PI)
European Commission - Horizon Europe
2025/04/01 → 2029/03/31
Project: Research
-
Inflammatoriska mekanismer och demensrisk efter traumatisk hjärnskada
Marklund, N. (PI)
2025/02/05 → 2026/12/31
Project: Research
-
Machine learning methods for parsing symptoms and treatment responses in Parkinson´s disease
Cenci Nilsson, A. (PI)
eSSENCE: The e-Science Collaboration
2025/02/05 → 2027/12/31
Project: Research
Infrastructure
-
Cellomics High Content Screening/Analysis
Hammarberg, A. (Manager)
Department of Experimental Medical ScienceInfrastructure
-
Chemical Biology Consortium Sweden – Lund
Olsson, R. (Manager) & Ek, F. (Contact)
Chemical Biology and TherapeuticsInfrastructure
-
Life Science Microfluidics
Wallman, L. (Manager), Laurell, T. (Coordinator), Meissner, A. (Coordinator), Baasch, T. (Contact), Bengtsson, M. (Contact) & Tojo, A. (Contact)
Division for Biomedical EngineeringInfrastructure
Activities
-
Fysisk aktivitet vid demenssjukdom- presentation grundutbildning fysioterpaeutprogrammet
Lindh-Rengifo, M. (Role not specified)
2025 Feb 20Activity: Talk or presentation › Presentation
-
Research Supervision
Thomas, O. (Participant), Deierborg, T. (Organiser), Regnér, S. (Organiser), von Konow, I. (Participant) & Iorizzo, L. (Participant)
2024 Nov 19 → 2024 Dec 10Activity: Participating in or organising an event › Participation in workshop/ seminar/ course
-
SVT: Ny behandling för Parkinson patienter ger hopp om ett bättre liv
Paul-Visse, G. (Interviewee)
2024 Oct 28Activity: Other › Media participation
Prizes and distinction
-
Malin Parmar and Roger Barker recieves the Oon Award for Preventative Medicine 2024
Parmar, M. (Recipient) & Barker, R. A. (Recipient), 2024 Mar
Prize: Prize (including medals and awards)
-
-